azimilide

Known as: 2,4-Imidazolidinedione, 1-(((5-(4-chlorophenyl)-2-furanyl)methylene)amino)-3-(4-(4-methyl-1-piperazinyl)butyl)-, azmilide 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2004
Highly Cited
2004
BACKGROUND Depressed left ventricular function (LVF) and low heart rate variability (HRV) identify patients at risk of increased… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2004
2004
BACKGROUND Although implanted cardioverter defibrillators (ICDs) effectively treat sustained ventricular tachyarrhythmias, up to… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2003
Highly Cited
2003
BACKGROUND Asymptomatic, or "silent" atrial fibrillation could increase the risk of stroke. Little is known about the frequency… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2001
Highly Cited
2001
BACKGROUND This study examined the role of phase 2 early afterdepolarization (EAD) in producing a trigger to initiate torsade de… (More)
Is this relevant?
2001
2001
We evaluated the efficacy and safety of azimilide, a new class III antiarrhythmic agent that blocks both the slow and fast… (More)
Is this relevant?
2001
2001
Torsade de Pointes arrhythmias are a feared proarrhythmic effect of (antiarrhythmic) drugs. In dogs with chronic complete AV… (More)
Is this relevant?
2000
2000
OBJECTIVES The purpose of this study was to assess the effectiveness of azimilide, a class III antiarrhythmic drug, in reducing… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
1999
1999
Azimilide (AZ) is a class III antiarrhythmic drug that has voltage-dependent dual effects on the HERG channel: 1) increasing… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
1998
1998
The AzimiLide post-Infarct surVival Evaluation (ALIVE) trial is a new clinical trial using an innovative design to examine the… (More)
Is this relevant?
1998
1998
1. The class III antiarrhythmic azimilide has previously been shown to inhibit I(Ks) and I(Kr) in guinea-pig cardiac myocytes and… (More)
Is this relevant?